enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Otsuka Pharmaceutical - Wikipedia

    en.wikipedia.org/wiki/Otsuka_Pharmaceutical

    Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.

  3. Statera BioPharma - Wikipedia

    en.wikipedia.org/wiki/Statera_BioPharma

    Statera BioPharma, Inc. is an American clinical-stage biopharmaceutical company with a focus on novel immunotherapies. In 2021, Cleveland BioLabs merged with Cytocom, Inc, a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases, and cancers. [1]

  4. Pharmavite - Wikipedia

    en.wikipedia.org/wiki/Pharmavite

    The Opelika, Alabama manufacturing facility opened in 2013 and is now the main manufacturer of gummy vitamins for the company. [19] [20] In 2021, there was an $8 million expansion of the facility. [21] In 2023, Pharmavite broke ground on a new production facility in New Albany, Ohio.

  5. Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc. - AOL

    lite.aol.com/tech/story/0022/20240801/9197265.htm

    Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc. 08/01/2024 04:01 -0400 - Transaction Includes JNT-517, a Potential First-In-Class Oral Treatment for Phenylketonuria (PKU) -

  6. Japan's Otsuka Pharma to pay up to $1.1 billion to acquire ...

    www.aol.com/news/japans-otsuka-pharma-pay-1...

    By Rocky Swift. TOKYO (Reuters) -Japan's Otsuka Pharmaceutical said on Thursday it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and ...

  7. Mark P. Frissora - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/mark-p-frissora

    From January 2009 to December 2012, if you bought shares in companies when Mark P. Frissora joined the board, and sold them when he left, you would have a 41.6 percent return on your investment, compared to a 69.3 percent return from the S&P 500.

  8. Astex Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Astex_Pharmaceuticals

    Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system.Astex was founded in 1999 by Sir Tom Blundell, [1] [2] Chris Abell & Harren Jhoti, [3] and is located in Cambridge, England.

  9. AOL latest headlines, entertainment, sports, articles for business, health and world news.